Results for biotechnology
[Guest Post] Enablement, Commercial Availability, and the Durability of Agro-Biotech Patents: Lessons from Inari v. Corteva [Guest Post] Enablement, Commercial Availability, and the Durability of Agro-Biotech Patents: Lessons from Inari v. Corteva Reviewed by Jocelyn Bosse on Thursday, December 18, 2025 Rating: 5
Intellectual Property Challenges in the Bio-Pharmaceutical Field Intellectual Property Challenges in the Bio-Pharmaceutical Field Reviewed by Mike Mireles on Wednesday, May 04, 2016 Rating: 5
The Evolution of U.S. Law and the Bio-Pharmaceutical Industry The Evolution of U.S. Law and the Bio-Pharmaceutical Industry Reviewed by Mike Mireles on Wednesday, April 06, 2016 Rating: 5
AIPPI Congress Report 2: Second medical use heats up a Sunday morning AIPPI Congress Report 2:  Second medical use heats up a Sunday morning Reviewed by Annsley Merelle Ward on Monday, September 15, 2014 Rating: 5
International patent filing strategy: a bio/pharma survey International patent filing strategy: a bio/pharma survey Reviewed by Jeremy on Friday, February 21, 2014 Rating: 5
Bundesgerichtshof refers human stem cell patent case to ECJ Bundesgerichtshof refers human stem cell patent case to ECJ Reviewed by Mark Schweizer on Sunday, November 15, 2009 Rating: 5
G 2/06: No EP patents for human embryo stem cells G 2/06: No EP patents for human embryo stem cells Reviewed by David Pearce on Friday, November 28, 2008 Rating: 5
New EPO enlarged board referral New EPO enlarged board referral Reviewed by David Pearce on Monday, June 11, 2007 Rating: 5

Stem cell patent

The Washington Post reports that the USPTO has revoked three patents granted to Wisconsin Alumni Research Foundation for inventions involvi...
- Friday, April 06, 2007
Stem cell patent Stem cell patent Reviewed by Anonymous on Friday, April 06, 2007 Rating: 5
Powered by Blogger.